TAIPEI, TAIWAN, Dec 1st, 2023- Intel's latest Agilex FPGA acceleration card has unlocked a new era of significant advancements in Genomics Acceleration. At WASAI, we proudly spearhead the acceleration of Genomics analysis tools on FPGA, delivering unparalleled performance while ensuring the most optimal Total Cost of Ownership (TCO). Research institutes and data centers can now seamlessly utilize FPGAs to execute dedicated genomic pipelines like GATK, which are offered as a comprehensive turnkey solution.
Our collaboration with Intel has been pivotal in integrating Sort and Duplicate tools onto the Agilex FPGA. This groundbreaking development was showcased by our acceleration card partner, BittWare, at SC23, the International Conference for High Performance Computing, in the United States in November. Commencing from November 30th to December 3rd, WASAI will also be presenting this demonstrative solution at the Healthcare Expo Taiwan 2023 hosted at the Intel Booth.
Intel's Agilex FPGA acceleration card represents a monumental leap in Genomic Computation capabilities. Our expertise in optimizing FPGA functionalities, in conjunction with Intel's state-of-the-art hardware, is driving Genomics research into unexplored realms.
This partnership remains steadfast in pushing the boundaries of Genomic acceleration, reshaping the scientific computing landscape, and unlocking unprecedented possibilities for groundbreaking discoveries in the realm of Genomics.
About WASAI Technology Inc.
WASAI Technology's mission is to deliver acceleration technologies of High-Performance Data Analysis (HPDA) in future data centers for targeted vertical applications with massive volumes and high velocities of scientific data. To strengthen and advance scientific discovery and technological research via big data-intensive acceleration in high-performance computing, WASAI Technology aims to improve commercialization and commoditization of scientific and technological applications.